The global market for Risperidone API was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
Risperidone(CAS锛�106266-06-2) is an atypical antipsychotic used to treat schizophrenia and bipolar disorder.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Risperidone API, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Risperidone API.
The Risperidone API market size, estimations, and forecasts are provided in terms of output/shipments (Kg) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Risperidone API market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Risperidone API manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, production, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Interquim SA
Inke S.A
Jai Radhe Sales
Dr. Reddy's Laboratories
Mylan
Teva
RPG Life Sciences Ltd.
Wuxi Jida Pharmaceutical Co., Ltd.
Venkata Narayana Active Ingredients
Torrent Pharmaceuticals Limited
Zhejiang Huahai Pharmaceutical
Icrom
Jubilant Generics
Jeil Pharmaceutical Co., Ltd
Aurobindo Pharma Limited
Enaltec Labs Private Limited
Anugraha Chemicals
Otto Brandes
Aurore Life Sciences
Guangzhou Tosun Pharmaceutical
Jiangsu Nhwa Pharmaceutical
by Type
Above 98 %
Above 99 %
by Application
Tablets
Oral Solution
Capsules
Others
Production by Region
North America
Europe
China
India
South Korea
Israel
Consumption by Region
North America
U.S.
Canada
Asia-Pacific
China
Japan
South Korea
China Taiwan
Southeast Asia
India
Europe
Germany
France
U.K.
Italy
Russia
Rest of Europe
Latin America, Middle East & Africa
Mexico
Brazil
Turkey
GCC Countries
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Risperidone API manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Production/output, value of Risperidone API by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.
Chapter 4: Consumption of Risperidone API in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.
Chapter 5: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 6: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.
Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 9: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 10: The main points and conclusions of the report.
Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.
1 Risperidone API Market Overview
1.1 Product Definition
1.2 Risperidone API by Type
1.2.1 Global Risperidone API Market Value Growth Rate Analysis by Type: 2024 VS 2031
1.2.2 Above 98 %
1.2.3 Above 99 %
1.3 Risperidone API by Application
1.3.1 Global Risperidone API Market Value Growth Rate Analysis by Application: 2024 VS 2031
1.3.2 Tablets
1.3.3 Oral Solution
1.3.4 Capsules
1.3.5 Others
1.4 Global Market Growth Prospects
1.4.1 Global Risperidone API Production Value Estimates and Forecasts (2020-2031)
1.4.2 Global Risperidone API Production Capacity Estimates and Forecasts (2020-2031)
1.4.3 Global Risperidone API Production Estimates and Forecasts (2020-2031)
1.4.4 Global Risperidone API Market Average Price Estimates and Forecasts (2020-2031)
1.5 Assumptions and Limitations
2 Market Competition by Manufacturers
2.1 Global Risperidone API Production Market Share by Manufacturers (2020-2025)
2.2 Global Risperidone API Production Value Market Share by Manufacturers (2020-2025)
2.3 Global Key Players of Risperidone API, Industry Ranking, 2023 VS 2024
2.4 Global Risperidone API Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
2.5 Global Risperidone API Average Price by Manufacturers (2020-2025)
2.6 Global Key Manufacturers of Risperidone API, Manufacturing Base Distribution and Headquarters
2.7 Global Key Manufacturers of Risperidone API, Product Offered and Application
2.8 Global Key Manufacturers of Risperidone API, Date of Enter into This Industry
2.9 Risperidone API Market Competitive Situation and Trends
2.9.1 Risperidone API Market Concentration Rate
2.9.2 Global 5 and 10 Largest Risperidone API Players Market Share by Revenue
2.10 Mergers & Acquisitions, Expansion
3 Risperidone API Production by Region
3.1 Global Risperidone API Production Value Estimates and Forecasts by Region: 2020 VS 2024 VS 2031
3.2 Global Risperidone API Production Value by Region (2020-2031)
3.2.1 Global Risperidone API Production Value by Region (2020-2025)
3.2.2 Global Forecasted Production Value of Risperidone API by Region (2026-2031)
3.3 Global Risperidone API Production Estimates and Forecasts by Region: 2020 VS 2024 VS 2031
3.4 Global Risperidone API Production Volume by Region (2020-2031)
3.4.1 Global Risperidone API Production by Region (2020-2025)
3.4.2 Global Forecasted Production of Risperidone API by Region (2026-2031)
3.5 Global Risperidone API Market Price Analysis by Region (2020-2025)
3.6 Global Risperidone API Production and Value, Year-over-Year Growth
3.6.1 North America Risperidone API Production Value Estimates and Forecasts (2020-2031)
3.6.2 Europe Risperidone API Production Value Estimates and Forecasts (2020-2031)
3.6.3 China Risperidone API Production Value Estimates and Forecasts (2020-2031)
3.6.4 India Risperidone API Production Value Estimates and Forecasts (2020-2031)
3.6.5 South Korea Risperidone API Production Value Estimates and Forecasts (2020-2031)
3.6.6 Israel Risperidone API Production Value Estimates and Forecasts (2020-2031)
4 Risperidone API Consumption by Region
4.1 Global Risperidone API Consumption Estimates and Forecasts by Region: 2020 VS 2024 VS 2031
4.2 Global Risperidone API Consumption by Region (2020-2031)
4.2.1 Global Risperidone API Consumption by Region (2020-2025)
4.2.2 Global Risperidone API Forecasted Consumption by Region (2026-2031)
4.3 North America
4.3.1 North America Risperidone API Consumption Growth Rate by Country: 2020 VS 2024 VS 2031
4.3.2 North America Risperidone API Consumption by Country (2020-2031)
4.3.3 U.S.
4.3.4 Canada
4.4 Europe
4.4.1 Europe Risperidone API Consumption Growth Rate by Country: 2020 VS 2024 VS 2031
4.4.2 Europe Risperidone API Consumption by Country (2020-2031)
4.4.3 Germany
4.4.4 France
4.4.5 U.K.
4.4.6 Italy
4.4.7 Russia
4.5 Asia Pacific
4.5.1 Asia Pacific Risperidone API Consumption Growth Rate by Region: 2020 VS 2024 VS 2031
4.5.2 Asia Pacific Risperidone API Consumption by Region (2020-2031)
4.5.3 China
4.5.4 Japan
4.5.5 South Korea
4.5.6 China Taiwan
4.5.7 Southeast Asia
4.5.8 India
4.6 Latin America, Middle East & Africa
4.6.1 Latin America, Middle East & Africa Risperidone API Consumption Growth Rate by Country: 2020 VS 2024 VS 2031
4.6.2 Latin America, Middle East & Africa Risperidone API Consumption by Country (2020-2031)
4.6.3 Mexico
4.6.4 Brazil
4.6.5 Turkey
4.6.6 GCC Countries
5 Segment by Type
5.1 Global Risperidone API Production by Type (2020-2031)
5.1.1 Global Risperidone API Production by Type (2020-2025)
5.1.2 Global Risperidone API Production by Type (2026-2031)
5.1.3 Global Risperidone API Production Market Share by Type (2020-2031)
5.2 Global Risperidone API Production Value by Type (2020-2031)
5.2.1 Global Risperidone API Production Value by Type (2020-2025)
5.2.2 Global Risperidone API Production Value by Type (2026-2031)
5.2.3 Global Risperidone API Production Value Market Share by Type (2020-2031)
5.3 Global Risperidone API Price by Type (2020-2031)
6 Segment by Application
6.1 Global Risperidone API Production by Application (2020-2031)
6.1.1 Global Risperidone API Production by Application (2020-2025)
6.1.2 Global Risperidone API Production by Application (2026-2031)
6.1.3 Global Risperidone API Production Market Share by Application (2020-2031)
6.2 Global Risperidone API Production Value by Application (2020-2031)
6.2.1 Global Risperidone API Production Value by Application (2020-2025)
6.2.2 Global Risperidone API Production Value by Application (2026-2031)
6.2.3 Global Risperidone API Production Value Market Share by Application (2020-2031)
6.3 Global Risperidone API Price by Application (2020-2031)
7 Key Companies Profiled
7.1 Interquim SA
7.1.1 Interquim SA Risperidone API Company Information
7.1.2 Interquim SA Risperidone API Product Portfolio
7.1.3 Interquim SA Risperidone API Production, Value, Price and Gross Margin (2020-2025)
7.1.4 Interquim SA Main Business and Markets Served
7.1.5 Interquim SA Recent Developments/Updates
7.2 Inke S.A
7.2.1 Inke S.A Risperidone API Company Information
7.2.2 Inke S.A Risperidone API Product Portfolio
7.2.3 Inke S.A Risperidone API Production, Value, Price and Gross Margin (2020-2025)
7.2.4 Inke S.A Main Business and Markets Served
7.2.5 Inke S.A Recent Developments/Updates
7.3 Jai Radhe Sales
7.3.1 Jai Radhe Sales Risperidone API Company Information
7.3.2 Jai Radhe Sales Risperidone API Product Portfolio
7.3.3 Jai Radhe Sales Risperidone API Production, Value, Price and Gross Margin (2020-2025)
7.3.4 Jai Radhe Sales Main Business and Markets Served
7.3.5 Jai Radhe Sales Recent Developments/Updates
7.4 Dr. Reddy's Laboratories
7.4.1 Dr. Reddy's Laboratories Risperidone API Company Information
7.4.2 Dr. Reddy's Laboratories Risperidone API Product Portfolio
7.4.3 Dr. Reddy's Laboratories Risperidone API Production, Value, Price and Gross Margin (2020-2025)
7.4.4 Dr. Reddy's Laboratories Main Business and Markets Served
7.4.5 Dr. Reddy's Laboratories Recent Developments/Updates
7.5 Mylan
7.5.1 Mylan Risperidone API Company Information
7.5.2 Mylan Risperidone API Product Portfolio
7.5.3 Mylan Risperidone API Production, Value, Price and Gross Margin (2020-2025)
7.5.4 Mylan Main Business and Markets Served
7.5.5 Mylan Recent Developments/Updates
7.6 Teva
7.6.1 Teva Risperidone API Company Information
7.6.2 Teva Risperidone API Product Portfolio
7.6.3 Teva Risperidone API Production, Value, Price and Gross Margin (2020-2025)
7.6.4 Teva Main Business and Markets Served
7.6.5 Teva Recent Developments/Updates
7.7 RPG Life Sciences Ltd.
7.7.1 RPG Life Sciences Ltd. Risperidone API Company Information
7.7.2 RPG Life Sciences Ltd. Risperidone API Product Portfolio
7.7.3 RPG Life Sciences Ltd. Risperidone API Production, Value, Price and Gross Margin (2020-2025)
7.7.4 RPG Life Sciences Ltd. Main Business and Markets Served
7.7.5 RPG Life Sciences Ltd. Recent Developments/Updates
7.8 Wuxi Jida Pharmaceutical Co., Ltd.
7.8.1 Wuxi Jida Pharmaceutical Co., Ltd. Risperidone API Company Information
7.8.2 Wuxi Jida Pharmaceutical Co., Ltd. Risperidone API Product Portfolio
7.8.3 Wuxi Jida Pharmaceutical Co., Ltd. Risperidone API Production, Value, Price and Gross Margin (2020-2025)
7.8.4 Wuxi Jida Pharmaceutical Co., Ltd. Main Business and Markets Served
7.8.5 Wuxi Jida Pharmaceutical Co., Ltd. Recent Developments/Updates
7.9 Venkata Narayana Active Ingredients
7.9.1 Venkata Narayana Active Ingredients Risperidone API Company Information
7.9.2 Venkata Narayana Active Ingredients Risperidone API Product Portfolio
7.9.3 Venkata Narayana Active Ingredients Risperidone API Production, Value, Price and Gross Margin (2020-2025)
7.9.4 Venkata Narayana Active Ingredients Main Business and Markets Served
7.9.5 Venkata Narayana Active Ingredients Recent Developments/Updates
7.10 Torrent Pharmaceuticals Limited
7.10.1 Torrent Pharmaceuticals Limited Risperidone API Company Information
7.10.2 Torrent Pharmaceuticals Limited Risperidone API Product Portfolio
7.10.3 Torrent Pharmaceuticals Limited Risperidone API Production, Value, Price and Gross Margin (2020-2025)
7.10.4 Torrent Pharmaceuticals Limited Main Business and Markets Served
7.10.5 Torrent Pharmaceuticals Limited Recent Developments/Updates
7.11 Zhejiang Huahai Pharmaceutical
7.11.1 Zhejiang Huahai Pharmaceutical Risperidone API Company Information
7.11.2 Zhejiang Huahai Pharmaceutical Risperidone API Product Portfolio
7.11.3 Zhejiang Huahai Pharmaceutical Risperidone API Production, Value, Price and Gross Margin (2020-2025)
7.11.4 Zhejiang Huahai Pharmaceutical Main Business and Markets Served
7.11.5 Zhejiang Huahai Pharmaceutical Recent Developments/Updates
7.12 Icrom
7.12.1 Icrom Risperidone API Company Information
7.12.2 Icrom Risperidone API Product Portfolio
7.12.3 Icrom Risperidone API Production, Value, Price and Gross Margin (2020-2025)
7.12.4 Icrom Main Business and Markets Served
7.12.5 Icrom Recent Developments/Updates
7.13 Jubilant Generics
7.13.1 Jubilant Generics Risperidone API Company Information
7.13.2 Jubilant Generics Risperidone API Product Portfolio
7.13.3 Jubilant Generics Risperidone API Production, Value, Price and Gross Margin (2020-2025)
7.13.4 Jubilant Generics Main Business and Markets Served
7.13.5 Jubilant Generics Recent Developments/Updates
7.14 Jeil Pharmaceutical Co., Ltd
7.14.1 Jeil Pharmaceutical Co., Ltd Risperidone API Company Information
7.14.2 Jeil Pharmaceutical Co., Ltd Risperidone API Product Portfolio
7.14.3 Jeil Pharmaceutical Co., Ltd Risperidone API Production, Value, Price and Gross Margin (2020-2025)
7.14.4 Jeil Pharmaceutical Co., Ltd Main Business and Markets Served
7.14.5 Jeil Pharmaceutical Co., Ltd Recent Developments/Updates
7.15 Aurobindo Pharma Limited
7.15.1 Aurobindo Pharma Limited Risperidone API Company Information
7.15.2 Aurobindo Pharma Limited Risperidone API Product Portfolio
7.15.3 Aurobindo Pharma Limited Risperidone API Production, Value, Price and Gross Margin (2020-2025)
7.15.4 Aurobindo Pharma Limited Main Business and Markets Served
7.15.5 Aurobindo Pharma Limited Recent Developments/Updates
7.16 Enaltec Labs Private Limited
7.16.1 Enaltec Labs Private Limited Risperidone API Company Information
7.16.2 Enaltec Labs Private Limited Risperidone API Product Portfolio
7.16.3 Enaltec Labs Private Limited Risperidone API Production, Value, Price and Gross Margin (2020-2025)
7.16.4 Enaltec Labs Private Limited Main Business and Markets Served
7.16.5 Enaltec Labs Private Limited Recent Developments/Updates
7.17 Anugraha Chemicals
7.17.1 Anugraha Chemicals Risperidone API Company Information
7.17.2 Anugraha Chemicals Risperidone API Product Portfolio
7.17.3 Anugraha Chemicals Risperidone API Production, Value, Price and Gross Margin (2020-2025)
7.17.4 Anugraha Chemicals Main Business and Markets Served
7.17.5 Anugraha Chemicals Recent Developments/Updates
7.18 Otto Brandes
7.18.1 Otto Brandes Risperidone API Company Information
7.18.2 Otto Brandes Risperidone API Product Portfolio
7.18.3 Otto Brandes Risperidone API Production, Value, Price and Gross Margin (2020-2025)
7.18.4 Otto Brandes Main Business and Markets Served
7.18.5 Otto Brandes Recent Developments/Updates
7.19 Aurore Life Sciences
7.19.1 Aurore Life Sciences Risperidone API Company Information
7.19.2 Aurore Life Sciences Risperidone API Product Portfolio
7.19.3 Aurore Life Sciences Risperidone API Production, Value, Price and Gross Margin (2020-2025)
7.19.4 Aurore Life Sciences Main Business and Markets Served
7.19.5 Aurore Life Sciences Recent Developments/Updates
7.20 Guangzhou Tosun Pharmaceutical
7.20.1 Guangzhou Tosun Pharmaceutical Risperidone API Company Information
7.20.2 Guangzhou Tosun Pharmaceutical Risperidone API Product Portfolio
7.20.3 Guangzhou Tosun Pharmaceutical Risperidone API Production, Value, Price and Gross Margin (2020-2025)
7.20.4 Guangzhou Tosun Pharmaceutical Main Business and Markets Served
7.20.5 Guangzhou Tosun Pharmaceutical Recent Developments/Updates
7.21 Jiangsu Nhwa Pharmaceutical
7.21.1 Jiangsu Nhwa Pharmaceutical Risperidone API Company Information
7.21.2 Jiangsu Nhwa Pharmaceutical Risperidone API Product Portfolio
7.21.3 Jiangsu Nhwa Pharmaceutical Risperidone API Production, Value, Price and Gross Margin (2020-2025)
7.21.4 Jiangsu Nhwa Pharmaceutical Main Business and Markets Served
7.21.5 Jiangsu Nhwa Pharmaceutical Recent Developments/Updates
8 Industry Chain and Sales Channels Analysis
8.1 Risperidone API Industry Chain Analysis
8.2 Risperidone API Raw Material Supply Analysis
8.2.1 Key Raw Materials
8.2.2 Raw Materials Key Suppliers
8.3 Risperidone API Production Mode & Process Analysis
8.4 Risperidone API Sales and Marketing
8.4.1 Risperidone API Sales Channels
8.4.2 Risperidone API Distributors
8.5 Risperidone API Customer Analysis
9 Risperidone API Market Dynamics
9.1 Risperidone API Industry Trends
9.2 Risperidone API Market Drivers
9.3 Risperidone API Market Challenges
9.4 Risperidone API Market Restraints
10 Research Findings and Conclusion
11 Methodology and Data Source
11.1 Methodology/Research Approach
11.1.1 Research Programs/Design
11.1.2 Market Size Estimation
11.1.3 Market Breakdown and Data Triangulation
11.2 Data Source
11.2.1 Secondary Sources
11.2.2 Primary Sources
11.3 Author List
11.4 Disclaimer
Interquim SA
Inke S.A
Jai Radhe Sales
Dr. Reddy's Laboratories
Mylan
Teva
RPG Life Sciences Ltd.
Wuxi Jida Pharmaceutical Co., Ltd.
Venkata Narayana Active Ingredients
Torrent Pharmaceuticals Limited
Zhejiang Huahai Pharmaceutical
Icrom
Jubilant Generics
Jeil Pharmaceutical Co., Ltd
Aurobindo Pharma Limited
Enaltec Labs Private Limited
Anugraha Chemicals
Otto Brandes
Aurore Life Sciences
Guangzhou Tosun Pharmaceutical
Jiangsu Nhwa Pharmaceutical
听
听
*If Applicable.
